SBRT Shows Promise for Localized Prostate Cancer
Hypofractionated stereotactic body radiotherapy achieves a good PSA response at a median of 24 months.
Hypofractionated stereotactic body radiotherapy achieves a good PSA response at a median of 24 months.
Men with severe oligoasthenospermia may be able to avoid testicular sperm retrieval, data suggest.
Patients with intermediate-risk prostate cancer benefit from androgen suppression plus radiotherapy.
The primary goal of treatment should be complete or partial remission of proteinuria.
Diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD among individuals who have had kidney stones, researchers reported in the American Journal of Kidney Diseases (2009; published online ahead of print).
Parathyroid gland enlargement may delay the response of secondary hyperparathyroidism to cinacalcet, Japanese researchers reported in Nephron Clinical Practice (2009; published online ahead of print).
Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.
Lovastatin may prevent development of cardiovascular disease (CVD) in CKD patients, according to study findings published in the American Journal of Kidney Diseases (2009; published online ahead of print).
Black men and Asian men are less likely to have severe erectile dysfunction (ED) than white men, according to a study of 78,445 men aged 45 to 69 years who were not diagnosed with prostate cancer.
Plasma copeptin, a marker of endogenous vasopressin levels, is associated with microalbuminuria, independent of age and other potential confounders, according to study findings published in Kidney International (2010;77:29-36).